Clinical Trial Update: Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin and paclitaxel for locally recurrent or metastatic nasopharyngeal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED